Atlas Trials

Assessment of the Optimal Dosing of Piperacillin-tazobactam in Intensive Care Unit Patients: Extended Versus Continuous Infusion

Clinical trial NCT01198925 · COMPLETED

Trial details

NCT number
NCT01198925
Sponsor
University Hospital, Ghent
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Infectious Disease
Start date
2010-09-23
Primary completion
2012-11-16
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.